Alita A Miller (Alita Miller)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Topics

Quality Control

Silver Nanoparticles

Top Venues

ACS infectious diseases

Antimicrobial agents and chemotherapy

Open forum infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Alita A Miller, Samir H Moussa, Sarah M McLeod
Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK). Antimicrobial agents and chemotherapy 68 (5) (2024)
Sarah M McLeod, Alita A Miller, Khurram Rana, David Altarac, Samir H Moussa, Adam B Shapiro
Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial Acinetobacter baumannii-calcoaceticus Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial. Open forum infectious diseases 11 (4) (2024)
Sarah M McLeod, Alita A Miller, Khurram Rana, David Altarac, Samir H Moussa, Adam B Shapiro
Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial Acinetobacter baumannii-calcoaceticus Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial. Open forum infectious diseases 11 (4) (2024)
Alita A Miller, Samir H Moussa, Sarah M McLeod
Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK). Antimicrobial agents and chemotherapy (2024)
Alita A Miller, Samir H Moussa, Sarah M McLeod
Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK). Antimicrobial agents and chemotherapy 68 (5) (2024)
Alita A Miller, Samir H Moussa, Sarah M McLeod
Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK). Antimicrobial agents and chemotherapy 68 (5) (2024)
Alita A Miller, Samir H Moussa, Sarah M McLeod
Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK). Antimicrobial agents and chemotherapy 68 (5) (2024)
Sarah M McLeod, Nicole M Carter, Michael D Huband, Maria M Traczewski, Patricia A Bradford, Alita A Miller
Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests. Journal of clinical microbiology (2023)
Samir H Moussa, Adam B Shapiro, Sarah M McLeod, Ramkumar Iyer, Nicole M Carter, Yu-Kuo Tsai, L Kristopher Siu, Alita A Miller
Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of Acinetobacter baumannii . Antimicrobial agents and chemotherapy (2023)
Khalid M Dousa, David C Nguyen, Sebastian G Kurz, Magdalena A Taracila, Christopher R Bethel, William Schinabeck, Barry N Kreiswirth, Sheldon T Brown, W Henry Boom, Richard S Hotchkiss, Kenneth E Remy, Frank J Jacono, Charles L Daley, Steven M Holland, Alita A Miller, Robert A Bonomo
Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action. mBio (2022)
James A Karlowsky, Meredith A Hackel, Sarah M McLeod, Alita A Miller
In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii - calcoaceticus Complex Collected from 2016 to 2021. Antimicrobial agents and chemotherapy 66 (9) (2022)
Thomas F Durand-Reville, Alita A Miller, John P O'Donnell, Xiaoyun Wu, Mark A Sylvester, Satenig Guler, Ramkumar Iyer, Adam B Shapiro, Nicole M Carter, Camilo Velez-Vega, Samir H Moussa, Sarah M McLeod, April Chen, Angela M Tanudra, Jing Zhang, Janelle Comita-Prevoir, Jan A Romero, Hoan Huynh, Andrew D Ferguson, Peter S Horanyi, Stephen J Mayclin, Henry S Heine, George L Drusano, Jason E Cummings, Richard A Slayden, Rubén A Tommasi
Rational design of a new antibiotic class for drug-resistant infections. Nature 597 (7878) (2021)
Krisztina M Papp-Wallace, Adam B Shapiro, Scott A Becka, Elise T Zeiser, John J LiPuma, Douglas J Lane, Rekha G Panchal, John P Mueller, John P O'Donnell, Alita A Miller
In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam-Durlobactam against Pathogenic Burkholderia Species. Antimicrobial agents and chemotherapy 65 (3) (2021)
Alita A Miller, Adam B Shapiro, Sarah M McLeod, Nicole M Carter, Samir H Moussa, Rubén A Tommasi, John P Mueller
In Vitro Characterization of ETX1317, a Broad-Spectrum β-Lactamase Inhibitor That Restores and Enhances β-Lactam Activity against Multi-Drug-Resistant Enterobacteriales, Including Carbapenem-Resistant Strains. ACS infectious diseases 6 (6) (2020)
Adam B Shapiro, Samir H Moussa, Nicole M Carter, Ning Gao, Alita A Miller
Ceftazidime-Avibactam Resistance Mutations V240G, D179Y, and D179Y/T243M in KPC-3 β-Lactamase Do Not Alter Cefpodoxime-ETX1317 Susceptibility. ACS infectious diseases 7 (1) (2020)
Thomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, Xiaoyun Wu, Tricia L May-Dracka, Jan Antoinette C Romero, Frank Wu, April Chen, Adam B Shapiro, Nicole M Carter, Sarah M McLeod, Robert A Giacobbe, Jeroen C Verheijen, Sushmita D Lahiri, Michael D Sacco, Yu Chen, John P O'Donnell, Alita A Miller, John P Mueller, Rubén A Tommasi
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases. Journal of medicinal chemistry 63 (21) (2020)
Patricia A Bradford, Alita A Miller, John P O'Donnell, John P Mueller
Zoliflodacin: An Oral Spiropyrimidinetrione Antibiotic for the Treatment of Neisseria gonorrheae, Including Multi-Drug-Resistant Isolates. ACS infectious diseases 6 (6) (2020)
Ramkumar Iyer, Samir H Moussa, Rubén A Tommasi, Alita A Miller
Titrating Levels of TolC in E. coli: A Sensitive Approach to Quantifying Efflux. ACS infectious diseases 5 (1) (2018)
Rubén A Tommasi, Ramkumar Iyer, Alita A Miller
Antibacterial Drug Discovery: Some Assembly Required. ACS infectious diseases 4 (5) (2018)
Adam B Shapiro, Ning Gao, Haris Jahić, Nicole M Carter, April Chen, Alita A Miller
Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514. ACS infectious diseases 3 (11) (2017)
Ramkumar Iyer, Samir H Moussa, Thomas F Durand-Réville, Ruben Tommasi, Alita A Miller
Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin. ACS infectious diseases 4 (3) (2017)
Ramkumar Iyer, Mark A Sylvester, Camilo Velez-Vega, Ruben Tommasi, Thomas F Durand-Reville, Alita A Miller
Whole-Cell-Based Assay To Evaluate Structure Permeation Relationships for Carbapenem Passage through the Pseudomonas aeruginosa Porin OprD. ACS infectious diseases 3 (4) (2017)